Fimasartan for Improvement of Diastolic Dysfunction in Hypertensive Patients

Trial Profile

Fimasartan for Improvement of Diastolic Dysfunction in Hypertensive Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jan 2016

At a glance

  • Drugs Fimasartan (Primary)
  • Indications Diastolic heart failure
  • Focus Therapeutic Use
  • Acronyms FINE
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 29 Dec 2015 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 22 Jun 2015 Planned End Date changed from 1 Apr 2015 to 1 Aug 2015 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top